NEW YORK (GenomeWeb News) - Complete Genomics will sequence glioblastoma and melanoma samples for the Broad Institute as part of a pilot study the company announced last month.

For the project, Complete Genomics will use its DNA sequencing technology to sequence five samples provided by the Broad Institute. The first genome will be a sample that has already been studied extensively by the scientific community. The other four genomes will include glioblastoma and melanoma samples and their matched normal controls.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.